US Supreme Court upholds "clear and convincing" patent standard, rules against Microsoft
This article was originally published in SRA
Executive Summary
Tiny Canadian tech firm i4i became the fighter that felled the giant on 9 June when the US Supreme Court in an 8-0 ruling upheld a $290 million judgment against Microsoft in a patent infringement case that has closely been watched by innovator drug makers, particularly small biotechs, as one of the most important patent lawsuits to go before the high court1.